HIV no barrier to getting liver transplant, study finds
(HealthDay)—Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.
HIV & AIDS
May 17, 2013 |
not rated yet |
0
Heart failure patients living longer, but long-term survival still low
People hospitalized for acute heart failure are likely to survive longer compared to the prior decade, according to a new study in the Journal of the American Heart Association and presented at the American Heart Association's ...
Cardiology
May 16, 2013 |
not rated yet |
0
Four genes indentified that influence levels of 'bad' cholesterol
Scientists at the Texas Biomedical Research Institute in San Antonio have identified four genes in baboons that influence levels of "bad" cholesterol. This discovery could lead to the development of new drugs to reduce the ...
Medical research
May 15, 2013 |
4.5 / 5 (2) |
0
|
Surgery can dramatically reduce genetic cancer risk
Women whose genes put them at a high risk of contracting breast cancer can dramatically reduce the danger by having a double mastectomy—but not eliminate it altogether, experts say.
Cancer
May 14, 2013 |
not rated yet |
0
Free testosterone drives cancer aggressiveness, study finds
What is the reason for the widely reported fact that men are more likely than women to die of cancer? New evidence from population studies suggests that free testosterone could be a key driver of cancer aggressiveness in ...
Cancer
May 14, 2013 |
5 / 5 (1) |
0
Popular diabetes drug does not improve survival rates after cancer
Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study from Women's College Hospital has found the drug may not actually improve survival rates ...
Diabetes
May 09, 2013 |
not rated yet |
0
Research reveals cancer-suppressing protein 'multitasks'
The understanding of how a powerful protein called p53 protects against cancer development has been upended by a discovery by Walter and Eliza Hall Institute researchers.
Cancer
May 09, 2013 |
4 / 5 (1) |
0
|
Soy and tomato combo may be effective in preventing prostate cancer
Tomatoes and soy foods may be more effective in preventing prostate cancer when they are eaten together than when either is eaten alone, said a University of Illinois study.
Cancer
May 08, 2013 |
5 / 5 (1) |
0
Prostate cancer may be deadlier for the uninsured
(HealthDay)—Men who are uninsured or underinsured get advanced prostate cancer at nearly four times the national average and don't survive as long as other men with advanced disease, a new study says.
Cancer
May 07, 2013 |
5 / 5 (1) |
0
Initiation of breast cancer treatment varies by race; patient-doctor communication is key
Black women with breast cancer were found to be three times more likely than their white counterparts to delay treatment for more than 90 days—a time delay associated with increased deaths from the disease, according to ...
Cancer
May 07, 2013 |
not rated yet |
0
Testicular cancer on rise in US, especially among Hispanic men
(HealthDay)—The number of testicular cancer cases continues to climb slowly but steadily in the United States, according to new research.
Cancer
May 03, 2013 |
3 / 5 (2) |
0
Chemo, radiation followed by surgery improves survival in lung cancer patients
In one of the largest observational studies of its kind, researchers report that a combination of chemotherapy and radiation followed by surgery in patients with stage 3 non-small cell lung cancer improves survival.
Cancer
Apr 30, 2013 |
not rated yet |
0
Team finds markers related to ovarian cancer survival and recurrence
(Medical Xpress)—Researchers at the University of Illinois have identified biomarkers that can be used to determine ovarian cancer survival and recurrence, and have shown how these biomarkers interact with ...
Cancer
Apr 30, 2013 |
not rated yet |
1
|
Postcode inequality for cancer diagnosis 'costs lives'
Hundreds of women with breast cancer living in England's most deprived areas would have better survival rates if they were diagnosed at the same stage as those who lived in affluent areas.
Cancer
Apr 29, 2013 |
not rated yet |
1
Chemoresponse assay helps boost ovarian cancer survival
This spring, a team of researchers has released results from an eight-year study that shows improved survival rates for women diagnosed with ovarian cancer who undergo cancer tumor testing to determine the best treatment.
Cancer
Apr 25, 2013 |
5 / 5 (1) |
0
